Crossmark

Positive predictive value of cervical cancer screening results recommended for colposcopy by human papillomavirus vaccination status at 3 U.S. healthcare systems

Crossref DOI link: https://doi.org/10.1007/s10552-025-02039-7

Published Online: 2025-08-06

Published Print: 2025-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pocobelli, Gaia

Lykken, Jacquelyn

Haas, Jennifer S.

Tiro, Jasmin

Doria-Rose, V. Paul

Hyun, Noorie

Silver, Michelle I.

Kamineni, Aruna

Chubak, Jessica
Funding

Funding for this research was provided by:

National Cancer Institute of the National Institutes of Health (UM1CA221940, UM1CA221940, UM1CA221940, UM1CA221940, UM1CA221940, UM1CA221940, UM1CA221940, UM1CA221940, UM1CA221940)
License Information

Text and Data Mining valid from 2025-08-06

Version of Record valid from 2025-08-06
More Information

Article History

Received: 27 February 2025

Accepted: 14 July 2025

First Online: 6 August 2025

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below